Single-center retrospective evaluation of a polymerase chain reaction-based pneumonia panel on antibiotic therapy...

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Pneumonia diagnosis often relies on traditional methods with variable turnaround times.
• Antimicrobial resistance necessitates precise pathogen identification for effective treatment.
• Optimizing antibiotic use is crucial, especially in elderly patient populations.

Purpose of the Study:

• To evaluate the clinical utility of a polymerase chain reaction-based pneumonia panel.
• To assess the impact of the panel on antibiotic stewardship in non-intensive care unit patients.
• To determine the rate of actionable results from molecular testing in pneumonia cases.

Main Methods:

• Retrospective analysis of 384 pneumonia cases.
• Utilized a multiplex polymerase chain reaction (PCR) panel for pathogen detection in sputum samples.
• Assessed the clinical impact and actionable nature of PCR results on antibiotic prescribing.

Main Results:

• The PCR-based pneumonia panel yielded actionable results in 87% (334/384) of cases.
• Identified key pathogens including atypical bacteria, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.
• Provided opportunities to streamline or escalate antibiotic therapy based on specific pathogen detection.

Conclusions:

• Polymerase chain reaction-based pneumonia panels offer significant value in clinical decision-making.
• The molecular testing approach supports targeted antibiotic stewardship, improving patient care.
• Rapid and accurate pathogen identification via PCR is beneficial for managing pneumonia in elderly, non-ICU settings.